IVBXF
Price
$12.13
Change
-$0.15 (-1.22%)
Updated
Sep 25 closing price
Capitalization
20.9B
MDWD
Price
$17.93
Change
+$0.23 (+1.30%)
Updated
Sep 26, 01:47 PM (EDT)
Capitalization
192.5M
53 days until earnings call
Interact to see
Advertisement

IVBXF vs MDWD

Header iconIVBXF vs MDWD Comparison
Open Charts IVBXF vs MDWDBanner chart's image
Innovent Biologics
Price$12.13
Change-$0.15 (-1.22%)
Volume$787
Capitalization20.9B
MediWound
Price$17.93
Change+$0.23 (+1.30%)
Volume$100
Capitalization192.5M
IVBXF vs MDWD Comparison Chart in %
Loading...
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVBXF vs. MDWD commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVBXF is a Hold and MDWD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (IVBXF: $12.14 vs. MDWD: $17.70)
Brand notoriety: IVBXF and MDWD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVBXF: 1% vs. MDWD: 108%
Market capitalization -- IVBXF: $20.9B vs. MDWD: $192.5M
IVBXF [@Biotechnology] is valued at $20.9B. MDWD’s [@Biotechnology] market capitalization is $192.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVBXF’s FA Score shows that 0 FA rating(s) are green whileMDWD’s FA Score has 1 green FA rating(s).

  • IVBXF’s FA Score: 0 green, 5 red.
  • MDWD’s FA Score: 1 green, 4 red.
According to our system of comparison, both IVBXF and MDWD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVBXF’s TA Score shows that 3 TA indicator(s) are bullish while MDWD’s TA Score has 4 bullish TA indicator(s).

  • IVBXF’s TA Score: 3 bullish, 5 bearish.
  • MDWD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both IVBXF and MDWD are a bad buy in the short-term.

Price Growth

IVBXF (@Biotechnology) experienced а -3.69% price change this week, while MDWD (@Biotechnology) price change was +2.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

MDWD is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVBXF($20.9B) has a higher market cap than MDWD($192M). IVBXF YTD gains are higher at: 169.667 vs. MDWD (-0.562).
IVBXFMDWDIVBXF / MDWD
Capitalization20.9B192M10,885%
EBITDAN/A-30.62M-
Gain YTD169.667-0.562-30,201%
P/E Ratio128.82N/A-
RevenueN/A19.9M-
Total CashN/A32.4M-
Total DebtN/A8.07M-
FUNDAMENTALS RATINGS
IVBXF vs MDWD: Fundamental Ratings
IVBXF
MDWD
OUTLOOK RATING
1..100
975
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
3854
P/E GROWTH RATING
1..100
614
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDWD's Valuation (66) in the Pharmaceuticals Other industry is in the same range as IVBXF (85) in the null industry. This means that MDWD’s stock grew similarly to IVBXF’s over the last 12 months.

IVBXF's Profit vs Risk Rating (66) in the null industry is somewhat better than the same rating for MDWD (100) in the Pharmaceuticals Other industry. This means that IVBXF’s stock grew somewhat faster than MDWD’s over the last 12 months.

IVBXF's SMR Rating (97) in the null industry is in the same range as MDWD (99) in the Pharmaceuticals Other industry. This means that IVBXF’s stock grew similarly to MDWD’s over the last 12 months.

IVBXF's Price Growth Rating (38) in the null industry is in the same range as MDWD (54) in the Pharmaceuticals Other industry. This means that IVBXF’s stock grew similarly to MDWD’s over the last 12 months.

MDWD's P/E Growth Rating (4) in the Pharmaceuticals Other industry is somewhat better than the same rating for IVBXF (61) in the null industry. This means that MDWD’s stock grew somewhat faster than IVBXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IVBXFMDWD
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 15 days ago
72%
Bullish Trend 16 days ago
75%
Declines
ODDS (%)
Bearish Trend 19 days ago
56%
Bearish Trend 10 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKTF0.630.04
+6.86%
Rock Tech Lithium Inc.
HBGRY1.07N/A
N/A
Heidelberger Druckmaschinen AG
TTDKF13.10-0.13
-0.97%
TDK Corp.
DPMLF21.24-0.23
-1.05%
DPM Metals Inc.
ALTPF0.04N/A
-2.09%
Altiplano Metals Inc.

IVBXF and

Correlation & Price change

A.I.dvisor tells us that IVBXF and WXXWY have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVBXF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVBXF
1D Price
Change %
IVBXF100%
-1.26%
WXXWY - IVBXF
22%
Poorly correlated
+1.92%
ONC - IVBXF
22%
Poorly correlated
-0.34%
MDWD - IVBXF
20%
Poorly correlated
-1.78%
IVEVF - IVBXF
15%
Poorly correlated
N/A
INTI - IVBXF
11%
Poorly correlated
+13.63%
More